期刊文献+

介入治疗房间隔缺损后神经内分泌因子及心指数的变化 被引量:2

Changes of neuroendocrine factor and cardiac index after interventional therapy
暂未订购
导出
摘要 目的观察成人先天性房间隔缺损(ASD)患者用国产Amplatzer封堵器介入治疗前后的神经内分泌因子及心指数(CI)的变化,探讨成人ASD患者神经内分泌的激活状况及与心功能的关系。方法检测30例成人ASD患者的心房钠尿肽(ANP)、脑钠尿肽(BNP)、内皮素-1(ET)及CI在介入治疗前、术后24 h、1个月、3个月、6个月的动态变化,另选取年龄及性别与之相匹配的正常体检成人30例作为对照组。结果成人ASD术前血循环中的ET(146±36)ng/L、ANP(148±30)ng/L、BNP(357±61)ng/L与对照组比较显著增高(均P<0.01),在介入治疗24 h后,均开始下降,至6个月基本下降至正常水平(P<0.01);术前的CI与对照组比较明显降低(P<0.05),在介入治疗24 h后,开始上升,至6个月基本恢复至正常水平(P<0.01)。血浆ANP、BNP和ET浓度与CI之间呈明显的负相关(相关系数分别是r=-0.56,P<0.01;r=-0.58,P<0.01;r=-0.45,P<0.05)。结论成人ASD存在神经内分泌的激活,并与CI呈负相关关系。介入治疗后其神经内分泌的功能及CI逐渐恢复正常。 AIM To detect the changes of neuroendocrine factor and cardiac index (CI) after interventional therapy, to explore whether neurohormonal activation exists in adults with congenital heart disease and to study the relationship between neuroendocrine factor and heart function. METHODS Concentrations of atrial natriuretic peptide ( ANP), brain natriuretic peptide (BNP) and endothelin ( ET), and CI were continuously detected in 30 adults with congenital heart disease, before interventional therapy and 24 h, 1 month, 3 months and 6 months after interventional therapy. Thirty cases of routine physical check-up were enrolled in the control group. RESULTS The adults with congenital heart disease had elevated levels of ET ( 146 ±36 vs 62 ± 10)ng/L, ANP ( 148 ±30 vs 81 ± 16)ng/L, BNP (357 ±61 vs 14 ± 6) ng/L, before interventional therapy ( all P 〈 0.01 ), which descended after interventional therapy and nearly recovered to normal level at the 6th month. In contrast, there were lower levels of CI [ 3.38 ± 0.29 vs 5.31 ± 0.21 ] L/( min ·m^2 ), which went up after interventional therapy and nearly recovered to normal level at the 6th month. CONCLUSION There is neurohormonal activation in adult congenital heart disease, which is negatively related to CI. The neuroendocrine function and CI gradually return to normal after interventional therapy.
出处 《心脏杂志》 CAS 2007年第1期51-52,56,共3页 Chinese Heart Journal
基金 广西科技攻关项目资助(桂科攻No.0472002-30)
关键词 房间隔缺损 先天性 介入治疗 神经内分泌因子 心脏指数 heart defect, congenital interventional therapy neuroendocrine factor cardiac index
  • 相关文献

参考文献9

  • 1Hoch M,Netz H.Heart failure in pediatric patients[J].Thorac Cardiovasc Surg,2005,53 (Suppl 2):S129-S134.
  • 2Ohuchi H,Suzuki H,Toyohara K,et al.Abnormal cardiac autonomic nervous activity after right ventricular outflow tract reconstruction[J].Circulation,2000,102(22):2732-2738.
  • 3Bolger AP,Sharma R,Li w,et al.Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease[J].Circulation,2002,106(1):92-99.
  • 4汪芳,李一石.脑钠素在心力衰竭诊治中的应用进展[J].临床心血管病杂志,2004,20(10):634-637. 被引量:12
  • 5Jourdain P,Funck F,Bellorini M,et al.Bedside B type natriuretic peptide and functional capacity in chronic heart failure[J].Eur J Heart Fail,2003,5(2):155-160.
  • 6Ohuchi H,Takasugi H,Ohashi H,et al.Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease[J].Circalation,2003,108(19):2368-2376.
  • 7胡海波,蒋世良,徐仲英,程飞,刘延龄,朱振辉.经导管VSD封堵术对左心室功能的影响[J].心脏杂志,2005,17(2):189-189. 被引量:3
  • 8Galie N,Manes A,Branzi A,et al.The endothelin system in pulmonary arterial hypertension[J].Cardiovasc Res,2004,61(2):227-237.
  • 9王瑶,陶则伟,陆贤,黄元伟.B型钠尿肽的研究进展[J].心脏杂志,2003,15(6):555-557. 被引量:41

二级参考文献24

  • 1de Bold A J. Bruneau B G, de Bold M L K. Mechanical and neuroendocrine regulation of the endocrine heart.Cardiovasc Res, 1996,31:7-18.
  • 2Schirger J A, Grantthan J A, Kullo I J, et al. Vascular actions of brain natriuretic peptide:modulation by atherosclerosis and neutral endopeptidase inhibition. J Am Coll Cardiol, 2000, 35: 76 - 81.
  • 3Flesicher D, Espiner E A, Yandle T G, et al. Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea. N Z Med J,1997.10:71-74.
  • 4Vogeser M, Jacob K. B-type natriuretic peptide-validation of an immediate response assay. Clin Lab, 2001,47:29-33.
  • 5Cowie M R. Struthers A D M,Wood D A, et al. Value of natriuretic peptide in assessment of patients with possible new heart failure in primary care. Lancet, 1997,350: 1349- 1351.
  • 6Dao Q. Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol,2001,37:379 -385.
  • 7Davidson N C, Naos A A, Hanson J K, et al. Comparision of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction . Am J Cardiol,1996,77:828-831.
  • 8Omland T, Aakvaag A, Bonarjee, W S,et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic dysfunction and long-term survival after acute myocardial infarction. Comparion with plasma atrial natriuretic peptide and N-terminal p
  • 9Nagaya N, Goto Y, Nishikimi T M,et al. Sustained elevation of plasma levels of brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction. Clin Sci, 1999,96:129-136.
  • 10Task force for the diagnosis and treatment of chronic heart failure ESC. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J, 2001,22:1527-1560.

共引文献53

同被引文献38

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部